Search results
Buy Biocon; target of Rs 400: Sharekhan
CNBC Awaaz· 4 days agoSharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 400 in its research report dated June 28, 2024.
HFT Scan: Ceat and India Cements in focus
CNBC Awaaz· 4 days agoCeat and India Cements closed higher on June 28.
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 5 days agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Dalal Street Week Ahead: FOMC minutes, Auto sales, FII activity among 10 key factors to watch next...
CNBC Awaaz· 5 days agoThe market is expected to trade sideways next week due to the absence of strong buying or selling...
Dividend Stocks: M&M, Piramal Ent, Tata Power, among others to trade ex-dividend next week; Check...
Livemint· 6 days agoDividend Stocks: Several companies including Mahindra & Mahindra, Piramal Enterprises, Tata Power,...
Defence component supplier TechEra Engineering to raise Rs 35 crore via IPO
CNBC Awaaz· 7 days agoThe price band is estimated to be in the range of Rs 75-80 and the company is looking to list by the second half of July, according to a person familiar with the process.
Taking Stock: Market fails to hold record high; surges 6.5% in June
CNBC Awaaz· 7 days agoFor the week, BSE Sensex and Nifty50 index added 2 percent each, however, for the month of June...